Immediate Impact
23 standout
Citing Papers
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
2024 Standout
Works of Jesús Alarcón being referenced
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)
2021
Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jesús Alarcón | 50 | 100 | 19 | 115 | 56 | 12 | 188 | |
| Dörte Wren | 67 | 48 | 12 | 44 | 29 | 16 | 182 | |
| Christina Parsons | 34 | 71 | 17 | 92 | 12 | 13 | 208 | |
| A. Alietti | 15 | 74 | 4 | 137 | 45 | 9 | 225 | |
| Rachel Wei | 41 | 166 | 5 | 138 | 124 | 17 | 259 | |
| Adi Broyde | 21 | 61 | 2 | 89 | 33 | 8 | 156 | |
| Kar Fai Chow | 11 | 37 | 5 | 79 | 50 | 18 | 155 | |
| Sabine Oeschger | 25 | 68 | 2 | 139 | 64 | 9 | 241 | |
| Elías Gracia | 71 | 153 | 2 | 125 | 27 | 14 | 283 | |
| Natalia Castrejón de Anta | 13 | 107 | 2 | 77 | 33 | 17 | 192 | |
| Catherine Vézina | 43 | 153 | 4 | 38 | 30 | 11 | 274 |
All Works
Loading papers...